WO2004045566A1 - 半透明化粧料 - Google Patents
半透明化粧料 Download PDFInfo
- Publication number
- WO2004045566A1 WO2004045566A1 PCT/JP2003/014249 JP0314249W WO2004045566A1 WO 2004045566 A1 WO2004045566 A1 WO 2004045566A1 JP 0314249 W JP0314249 W JP 0314249W WO 2004045566 A1 WO2004045566 A1 WO 2004045566A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- component
- translucent
- ceramide
- polyoxyethylene
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Definitions
- the present invention relates to a translucent cosmetic, and more particularly to a translucent cosmetic having a ceramide-containing emulsified / w / w emulsion which has excellent stability over time, has a beautiful appearance, and has a high-class feel.
- Ceramide is present in the stratum corneum of the skin and plays an important role in building the lipid parlia necessary for water retention and maintaining water. Ceramide in the stratum corneum is produced by the decomposition of cerebroside by an enzyme called cereb mouth fern. Some ceramides are converted to phytosphingosine and sphingosine by an enzyme called ceramidase, and are known to be important as regulators of cell growth and differentiation. There are six different types of ceramide in human skin, each with different functions. However, ceramide is a highly crystalline substance, has low solubility in other oils, and precipitates crystals at low temperatures. It was difficult.
- lipid dispersion composition in which a phospholipid and a polyhydric alcohol are blended in order to stably blend ceramide is disclosed (see, for example, Japanese Patent Application Laid-Open No. 11-135,651).
- an object of the present invention is to provide an OZW emulsification type cosmetic containing ceramide, which has excellent stability over time while reducing the amount of a surfactant, and has a visual beauty and a high-grade appearance.
- the aim is to provide translucent cosmetics that can be given. Disclosure of invention
- the present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, have at least a ceramide, an oily component, a nonionic surfactant and water, and the average particle size of the ⁇ zw emulsion is 100
- the present inventors have found that a translucent cosmetic having a wavelength of from 300 nm to 300 nm has excellent stability over time, and completed the present invention.
- the present invention is as follows.
- the above translucent cosmetic wherein the nonionic surfactant of the component (c) is polyoxyethylene hydrogenated castor oil.
- the total mass of the ceramide of the component (a) and the oily component of the component (b) and the blending mass ratio of the nonionic surfactant of the component (c) are from 3: 1 to 1.2: 1. Translucent cosmetics.
- Component (b) The translucent cosmetic as described above, wherein the oily component contains isostearic acid.
- nonionic surfactant of the component (c) is polyoxyethylene (60) hydrogenated castor oil.
- the ceramide of component (a) used in the present invention is not particularly limited as long as it is generally used in cosmetics. Specific examples thereof include ceramide produced using yeast, and simulated chemamide by chemical synthesis. Ceramides, ceramides obtained from plants, and the like, for example, ceramides 1 to 6 are exemplified. These can be used alone or in combination of two or more as necessary. Among them, ceramide 2 or ceramide 3 is more preferable for obtaining excellent stability over time.
- the oily component (b) used in the present invention realizes an OZW emulsion having an average particle size of 100 11111 to 300 nm and makes the cosmetic translucent to give visual beauty and luxury.
- the above is an essential component.
- the component (b) is not particularly limited as long as it is commonly used in cosmetics. Specific examples include hydrocarbons, oils and fats, waxes, hardened oils, ester oils, and the like. Fatty acids, higher alcohols, sterols, silicone oils, fluorinated oils, lanolin derivatives, oil-soluble vitamins, vegetable oils and the like.
- sterols such as phytosterol containing cholesterol, campesterol, sitosterol, and stigmasterol are more preferably used because an excellent emulsification stability improving effect is obtained.
- component (b) When fatty acids such as stearic acid, lauric acid, myristic acid, behenic acid, isostearic acid, and oleic acid are contained as component (b), excellent solubility in component (a) and improvement in stability over time can be obtained. Obtained and more preferred, of which isostearic acid is particularly preferred.
- isostearic acid any of those derived from dimer acid, those derived from the Garbet reaction, and those derived from the aldehyde condensation reaction can be suitably used.
- the nonionic surfactant of component (c) used in the present invention is an essential component for obtaining excellent emulsion stability.
- the component (c) is not particularly limited as long as it is generally used in cosmetics. Specific examples include polyoxyethylene glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene sorbin fatty acid ester, Polyoxyethylene hydrogenated castor oil, polyoxyethylene cholesteryl ether, polyoxyethylene phytosteryl ether, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene alkylphenyl ether, alkyl darcoside No. These can be used alone or in combination of two or more as needed.
- the water of the component (d) used in the present invention is an essential component for constituting an OZW emulsified translucent cosmetic.
- the translucent cosmetic of the present invention composed of the above components, it is an essential condition that the average particle size of the emulsion is 100 nm to 300 nm. If the average particle size of the emulsion is less than 10 Onm, coalescence of the emulsion may occur with the lapse of time, and if it exceeds 300 nm, creaming may occur. It is difficult.
- the present invention is based on the fact that the average particle size of the emulsion is 100 nm to 300 nm.
- the average particle size of the emulsion is more preferably 150 nm to 250 nm.
- the emulsion does not become transparent as in a solubilized system, and the emulsion has a large amount of oily components.
- the appearance does not become cloudy, the appearance can be made translucent, and a luxury cosmetic can be provided.
- ⁇ semi-transparent '' means that the transmittance of light with a wavelength of 60 Onm in a 1 cm square quartz cell is 2% to 45% using a UV-2500PC UV-VIS REDCORDING SPECTROPHOTOMETER manufactured by SHIMADZU.
- component (a) and component (b) used in the present invention are not particularly limited, but in order to obtain excellent stability over time, the total of component (a) and component (b) is required.
- the amount is preferably from 0.01 to 10% by mass (hereinafter abbreviated as "%") with respect to the entire translucent cosmetic, and more preferably from 0.05 to 5%.
- the amount of the component (c) in the present invention is about 0.004% to 4%, preferably about 0.02% to 0.2%, based on the entire translucent cosmetic.
- the total weight of the component (a) and the component (b) and the blending mass ratio of the component (c) are 3: 1 to 1.2: 1. It is particularly preferred that the ratio be 2.5: 1 to 1.5: 1.
- surfactants were often used in excess of the total amount of ceramide and fat components, but by adjusting the amount in the above range, the usability was not impaired, the aging stability was excellent, and It is possible to provide a translucent cosmetic with a good feeling.
- the translucent cosmetic of the present invention includes, in addition to the above essential components, a surfactant other than the nonionic surfactant, a gelling agent, a water-soluble polymer (animal / plant-based, microbial-based, synthetic-based), an antioxidant , PH regulators, fragrances, antibacterial agents, preservatives, fresheners, moisturizers, anti-inflammatory agents, whitening agents, cell activators, skin roughness improvers, blood circulation enhancers, skin astringents, ultraviolet absorbers, etc. It can be blended within a range that does not impair the effects of the invention.
- the method for producing the translucent cosmetic of the present invention is not particularly limited, and it is produced by a device capable of ordinary emulsification and mixing, if necessary, through steps such as heating and cooling. .
- a specific production method there can be mentioned a method in which the component (a), the component (b) and the component (c) are uniformly heated and mixed, and then added to the component (d) and emulsified.
- each component may be adjusted. Can be easily achieved by setting the blending mass ratio of the total amount of the components (a) and (b) and the component (c).
- component (a), component (b) and component (c) are mixed and dissolved in a polyhydric alcohol such as 1,3-butylene glycol at 90. And a production method in which this is added to the aqueous component heated to 80.
- a polyhydric alcohol such as 1,3-butylene glycol
- Examples of the use of the translucent cosmetic of the present invention obtained as described above include skin lotions, serums, massages, packs, skin care cosmetics such as hand jewels and body jewels, and cosmetic base cosmetics.
- the method of use includes a method of using by hand, a method of impregnating a nonwoven fabric or the like, and the like.
- the translucent cosmetic of the present invention described above has a translucent appearance because the OZW emulsion contained therein has an average particle size in the range of 100 to 300 nm. It can give a sense of luxury.
- a serum was prepared according to the composition shown in Table 1 and the following production method.
- the (i) average particle size of the emulsion, (ii) translucency, and (iii) aging stability of the obtained serum were evaluated by the following methods. The results are also shown in Table 1.
- A was added to B, emulsified, and cooled to obtain a serum.
- the average particle size of the emulsion of the obtained serum was measured using a SUB-MICRON PART I CLE ANALYZER MODEL N4SD (manufactured by Coulter Inc.).
- each serum sample was placed in a 1 cm square quartz cell, and the transmittance was measured with light having a wavelength of 60 Onm.
- Each serum sample was stored in a 50 ° C, 50 ° C thermostat for one month.
- the condition immediately after preparation was used as a control to visually check the appearance (turbidity, separation, creaming) for the following changes.
- the determination was made using a step determination criterion.
- the skin lotion emulsion obtained as described above had an average particle size of 200 nm, was translucent in appearance, and had excellent stability over time.
- Example 10
- the emulsion of the serum obtained as described above had an average particle size of 210 nm, was translucent in appearance, and was excellent in stability over time. Industrial applicability
- the present invention can widely utilize the excellent effects of ceramide and the retention of skin moisture in cosmetics. Further, in the translucent cosmetic of the present invention, the amount of the surfactant can be reduced as compared with a conventional cosmetic of the same kind, so that a cosmetic excellent in safety and usability can be obtained.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/534,986 US20060057091A1 (en) | 2002-11-15 | 2003-11-10 | Semitransparent cosmetics |
| AU2003277638A AU2003277638A1 (en) | 2002-11-15 | 2003-11-10 | Semitransparent cosmetics |
| JP2004553151A JP4504195B2 (ja) | 2002-11-15 | 2003-11-10 | 半透明化粧料 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002331789 | 2002-11-15 | ||
| JP2002-331789 | 2002-11-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004045566A1 true WO2004045566A1 (ja) | 2004-06-03 |
Family
ID=32321640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2003/014249 Ceased WO2004045566A1 (ja) | 2002-11-15 | 2003-11-10 | 半透明化粧料 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060057091A1 (ja) |
| JP (1) | JP4504195B2 (ja) |
| KR (1) | KR101068901B1 (ja) |
| CN (1) | CN1319508C (ja) |
| AU (1) | AU2003277638A1 (ja) |
| TW (1) | TW200413011A (ja) |
| WO (1) | WO2004045566A1 (ja) |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006199598A (ja) * | 2005-01-18 | 2006-08-03 | Chanson Keshohin Kk | 皮膚化粧料、その製造方法及びその使用方法 |
| JP2006248925A (ja) * | 2005-03-08 | 2006-09-21 | Kose Corp | パール剤組成物及びそれを含有する化粧料 |
| JP2006312622A (ja) * | 2005-04-06 | 2006-11-16 | Kao Corp | 水中油型エマルション及びその製造方法 |
| JP2007070304A (ja) * | 2005-09-08 | 2007-03-22 | Hakuto Co Ltd | 化粧料およびその製造方法 |
| JP2008001620A (ja) * | 2006-06-21 | 2008-01-10 | Kao Corp | ピールオフパック |
| JP2008050305A (ja) * | 2006-08-24 | 2008-03-06 | Toyo Shinyaku:Kk | 化粧料組成物 |
| EP2056824A4 (en) * | 2006-08-09 | 2009-09-23 | Lipo Chemicals Inc | TOPICAL CERAMIDE COMPOSITIONS AND METHODS OF USE |
| JP2012077000A (ja) * | 2010-09-30 | 2012-04-19 | Kose Corp | 水中油型乳化化粧料 |
| JP2012077001A (ja) * | 2010-09-30 | 2012-04-19 | Kose Corp | 水中油型乳化化粧料 |
| JP2012092021A (ja) * | 2010-10-25 | 2012-05-17 | Fancl Corp | 水中油型乳化組成物 |
| JP2013155163A (ja) * | 2012-01-31 | 2013-08-15 | Asanuma Corporation | 化粧料 |
| JP2013189408A (ja) * | 2012-03-15 | 2013-09-26 | Shiseido Co Ltd | 半透明化粧料 |
| JP2016088860A (ja) * | 2014-10-31 | 2016-05-23 | 株式会社コーセー | 化粧料又は皮膚外用剤 |
| WO2017110151A1 (en) | 2015-12-22 | 2017-06-29 | L'oreal | Topical delivery system for active ingredients |
| WO2018070305A1 (ja) | 2016-10-14 | 2018-04-19 | 株式会社ダイセル | 化粧料組成物 |
| WO2019131987A1 (ja) * | 2017-12-28 | 2019-07-04 | 花王株式会社 | 脂質微粒子分散物 |
| JP2019196311A (ja) * | 2018-04-16 | 2019-11-14 | ロレアル | O/w型の形態の組成物 |
| WO2020175700A1 (ja) * | 2019-02-28 | 2020-09-03 | 株式会社日本触媒 | 化粧料用水性分散体、化粧料組成物、及び化粧料の製造方法 |
| JP2021113155A (ja) * | 2020-01-16 | 2021-08-05 | 株式会社ファンケル | 化粧料 |
| FR3115691A1 (fr) | 2020-10-30 | 2022-05-06 | L'oreal | Composition de soin de la peau |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4879934B2 (ja) * | 2008-05-09 | 2012-02-22 | 富士フイルム株式会社 | 外用組成物およびその製造方法 |
| US8642052B2 (en) * | 2008-09-30 | 2014-02-04 | Fujifilm Corporation | Ceramide dispersion and method for producing same |
| JP4959663B2 (ja) * | 2008-09-30 | 2012-06-27 | 富士フイルム株式会社 | 水性化粧料及びその製造方法 |
| JP5676319B2 (ja) * | 2010-04-07 | 2015-02-25 | 富士フイルム株式会社 | 水性化粧料の製造方法 |
| JP6134678B2 (ja) * | 2014-03-14 | 2017-05-24 | 富士フイルム株式会社 | セラミド分散組成物の製造方法 |
| JP2015196663A (ja) * | 2014-04-01 | 2015-11-09 | ロレアル | ナノ又はマイクロエマルションの形態の組成物 |
| CN106420595A (zh) * | 2016-11-30 | 2017-02-22 | 广州市花安堂生物科技有限公司 | 一种透明柔肤水及其制备方法 |
| CN106420594A (zh) * | 2016-11-30 | 2017-02-22 | 广州市花安堂生物科技有限公司 | 一种透明柔肤水及其制备方法 |
| CN106420426A (zh) * | 2016-11-30 | 2017-02-22 | 广州市花安堂生物科技有限公司 | 一种透明面膜及其制备方法 |
| CN106511256A (zh) * | 2016-11-30 | 2017-03-22 | 广州市花安堂生物科技有限公司 | 一种透明面膜及其制备方法 |
| KR102451838B1 (ko) * | 2017-09-01 | 2022-10-11 | (주)아모레퍼시픽 | 고함량 오일 내상을 안정화한 수중유형 화장료 조성물 |
| KR102500905B1 (ko) * | 2020-12-24 | 2023-02-17 | 주식회사 넥스텍인터내셔널 | 천연 세라마이드를 함유한 반투명 제형의 나노에멀젼 및 이를 포함한 화장료 조성물 |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0115395A2 (en) * | 1983-01-26 | 1984-08-08 | International Computers Limited | Computer processor system with software protection |
| JPS63141908A (ja) * | 1986-12-03 | 1988-06-14 | Kanebo Ltd | 乳化型化粧料 |
| JPS63192703A (ja) * | 1987-02-04 | 1988-08-10 | Kao Corp | 皮膚外用剤 |
| JPH08109121A (ja) * | 1994-10-13 | 1996-04-30 | Kao Corp | 化粧料 |
| JPH09124432A (ja) * | 1995-10-26 | 1997-05-13 | Kanebo Ltd | 液晶型エマルションの製造方法および該製造方法によって得られる液晶型エマルション組成物 |
| US5658575A (en) * | 1993-09-07 | 1997-08-19 | L'oreal | Cosmetic or dermatological composition comprising an oil-in-water emulsion based on oily globules provided with a lamellar liquid crystal coating |
| JPH11335261A (ja) * | 1998-05-11 | 1999-12-07 | Ciba Specialty Chem Holding Inc | 化粧品最終処方物におけるナノディスパ―ジョンの使用 |
| JP2000063234A (ja) * | 1998-08-19 | 2000-02-29 | Kose Corp | 水中油型化粧料 |
| JP2000128733A (ja) * | 1998-10-23 | 2000-05-09 | Lion Corp | O/w型エマルション及びその製造方法 |
| JP2000264826A (ja) * | 1999-03-16 | 2000-09-26 | Ryuhodo Seiyaku Kk | 液晶組成物およびそれが配合されてなる皮膚化粧料 |
| EP1236462A1 (en) * | 2001-02-28 | 2002-09-04 | Neopharm Co., Ltd. | Multi-lamella based emulsion for stabilizing dermatologically useful ingredients and external preparation containing the same |
| JP2002302414A (ja) * | 2000-12-26 | 2002-10-18 | Kokuriyuudou:Kk | スフィンゴ脂質構造物質含有乳化組成物及びその製造方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW453881B (en) * | 1995-10-16 | 2001-09-11 | Kao Corp | Cosmetic composition comprising amide derivatives |
| BRPI9807124B8 (pt) * | 1997-12-05 | 2021-05-25 | Cosmoferm Bv | composições compreendendo uma combinação de uma base esfingóide livre e uma ceramida e seus usos. |
| JP4350269B2 (ja) * | 2000-05-11 | 2009-10-21 | 高砂香料工業株式会社 | 化粧料添加用組成物 |
-
2003
- 2003-11-10 WO PCT/JP2003/014249 patent/WO2004045566A1/ja not_active Ceased
- 2003-11-10 JP JP2004553151A patent/JP4504195B2/ja not_active Expired - Lifetime
- 2003-11-10 AU AU2003277638A patent/AU2003277638A1/en not_active Abandoned
- 2003-11-10 CN CNB2003801033731A patent/CN1319508C/zh not_active Expired - Lifetime
- 2003-11-10 US US10/534,986 patent/US20060057091A1/en not_active Abandoned
- 2003-11-10 KR KR1020057008691A patent/KR101068901B1/ko not_active Expired - Lifetime
- 2003-11-12 TW TW092131697A patent/TW200413011A/zh not_active IP Right Cessation
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0115395A2 (en) * | 1983-01-26 | 1984-08-08 | International Computers Limited | Computer processor system with software protection |
| JPS63141908A (ja) * | 1986-12-03 | 1988-06-14 | Kanebo Ltd | 乳化型化粧料 |
| JPS63192703A (ja) * | 1987-02-04 | 1988-08-10 | Kao Corp | 皮膚外用剤 |
| US5658575A (en) * | 1993-09-07 | 1997-08-19 | L'oreal | Cosmetic or dermatological composition comprising an oil-in-water emulsion based on oily globules provided with a lamellar liquid crystal coating |
| JPH08109121A (ja) * | 1994-10-13 | 1996-04-30 | Kao Corp | 化粧料 |
| JPH09124432A (ja) * | 1995-10-26 | 1997-05-13 | Kanebo Ltd | 液晶型エマルションの製造方法および該製造方法によって得られる液晶型エマルション組成物 |
| JPH11335261A (ja) * | 1998-05-11 | 1999-12-07 | Ciba Specialty Chem Holding Inc | 化粧品最終処方物におけるナノディスパ―ジョンの使用 |
| JP2000063234A (ja) * | 1998-08-19 | 2000-02-29 | Kose Corp | 水中油型化粧料 |
| JP2000128733A (ja) * | 1998-10-23 | 2000-05-09 | Lion Corp | O/w型エマルション及びその製造方法 |
| JP2000264826A (ja) * | 1999-03-16 | 2000-09-26 | Ryuhodo Seiyaku Kk | 液晶組成物およびそれが配合されてなる皮膚化粧料 |
| JP2002302414A (ja) * | 2000-12-26 | 2002-10-18 | Kokuriyuudou:Kk | スフィンゴ脂質構造物質含有乳化組成物及びその製造方法 |
| EP1236462A1 (en) * | 2001-02-28 | 2002-09-04 | Neopharm Co., Ltd. | Multi-lamella based emulsion for stabilizing dermatologically useful ingredients and external preparation containing the same |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006199598A (ja) * | 2005-01-18 | 2006-08-03 | Chanson Keshohin Kk | 皮膚化粧料、その製造方法及びその使用方法 |
| JP2006248925A (ja) * | 2005-03-08 | 2006-09-21 | Kose Corp | パール剤組成物及びそれを含有する化粧料 |
| JP2006312622A (ja) * | 2005-04-06 | 2006-11-16 | Kao Corp | 水中油型エマルション及びその製造方法 |
| JP2007070304A (ja) * | 2005-09-08 | 2007-03-22 | Hakuto Co Ltd | 化粧料およびその製造方法 |
| JP2008001620A (ja) * | 2006-06-21 | 2008-01-10 | Kao Corp | ピールオフパック |
| EP2056824A4 (en) * | 2006-08-09 | 2009-09-23 | Lipo Chemicals Inc | TOPICAL CERAMIDE COMPOSITIONS AND METHODS OF USE |
| JP2008050305A (ja) * | 2006-08-24 | 2008-03-06 | Toyo Shinyaku:Kk | 化粧料組成物 |
| JP2012077000A (ja) * | 2010-09-30 | 2012-04-19 | Kose Corp | 水中油型乳化化粧料 |
| JP2012077001A (ja) * | 2010-09-30 | 2012-04-19 | Kose Corp | 水中油型乳化化粧料 |
| JP2012092021A (ja) * | 2010-10-25 | 2012-05-17 | Fancl Corp | 水中油型乳化組成物 |
| JP2013155163A (ja) * | 2012-01-31 | 2013-08-15 | Asanuma Corporation | 化粧料 |
| JP2013189408A (ja) * | 2012-03-15 | 2013-09-26 | Shiseido Co Ltd | 半透明化粧料 |
| JP2016088860A (ja) * | 2014-10-31 | 2016-05-23 | 株式会社コーセー | 化粧料又は皮膚外用剤 |
| WO2017110151A1 (en) | 2015-12-22 | 2017-06-29 | L'oreal | Topical delivery system for active ingredients |
| WO2018070305A1 (ja) | 2016-10-14 | 2018-04-19 | 株式会社ダイセル | 化粧料組成物 |
| KR20190068576A (ko) | 2016-10-14 | 2019-06-18 | 주식회사 다이셀 | 화장료 조성물 |
| US10933004B2 (en) | 2016-10-14 | 2021-03-02 | Daicel Corporation | Cosmetic composition |
| US11564871B2 (en) | 2017-12-28 | 2023-01-31 | Kao Corporation | Dispersion of fine lipid particle dispersion |
| WO2019131987A1 (ja) * | 2017-12-28 | 2019-07-04 | 花王株式会社 | 脂質微粒子分散物 |
| JP2019119742A (ja) * | 2017-12-28 | 2019-07-22 | 花王株式会社 | 脂質微粒子分散物 |
| JP7278769B2 (ja) | 2017-12-28 | 2023-05-22 | 花王株式会社 | 脂質微粒子分散物 |
| JP2019196311A (ja) * | 2018-04-16 | 2019-11-14 | ロレアル | O/w型の形態の組成物 |
| WO2020175700A1 (ja) * | 2019-02-28 | 2020-09-03 | 株式会社日本触媒 | 化粧料用水性分散体、化粧料組成物、及び化粧料の製造方法 |
| JPWO2020175700A1 (ja) * | 2019-02-28 | 2021-10-07 | 株式会社日本触媒 | 化粧料用水性分散体、化粧料組成物、及び化粧料の製造方法 |
| JP2021113155A (ja) * | 2020-01-16 | 2021-08-05 | 株式会社ファンケル | 化粧料 |
| JP7411421B2 (ja) | 2020-01-16 | 2024-01-11 | 株式会社ファンケル | 化粧料 |
| FR3115691A1 (fr) | 2020-10-30 | 2022-05-06 | L'oreal | Composition de soin de la peau |
Also Published As
| Publication number | Publication date |
|---|---|
| TW200413011A (en) | 2004-08-01 |
| US20060057091A1 (en) | 2006-03-16 |
| TWI317287B (ja) | 2009-11-21 |
| JP4504195B2 (ja) | 2010-07-14 |
| KR101068901B1 (ko) | 2011-09-29 |
| CN1319508C (zh) | 2007-06-06 |
| AU2003277638A1 (en) | 2004-06-15 |
| JPWO2004045566A1 (ja) | 2006-03-16 |
| CN1711067A (zh) | 2005-12-21 |
| KR20050075017A (ko) | 2005-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004045566A1 (ja) | 半透明化粧料 | |
| JP4527530B2 (ja) | ベシクル分散物およびこれを含有する化粧料 | |
| JP5758670B2 (ja) | 水中油型乳化組成物 | |
| JP5101808B2 (ja) | 水中油型液状組成物 | |
| JP2014208626A (ja) | リポソーム組成物 | |
| JPH0667818B2 (ja) | 半透明乳化化粧料 | |
| JP2001187711A (ja) | 化粧料 | |
| CN113101239A (zh) | 一种多相包裹微乳化洁颜油及其制备方法 | |
| KR20160082054A (ko) | 유화제를 함유하지 않는 수중유 유화형 화장료 조성물 및 이의 제조방법 | |
| JPH09309813A (ja) | 皮膚外用剤 | |
| JP4731301B2 (ja) | 保湿剤及びこれを含有する化粧料 | |
| EP0375082B1 (en) | Cosmetic composition | |
| JP3996488B2 (ja) | 乳化化粧料 | |
| JPH08183726A (ja) | 皮膚外用剤 | |
| KR101261388B1 (ko) | 소듐폴리감마글루타메이트의 효능향상을 위한 조성물 및 이의 캡슐화 방법 및 이를 포함하는 화장료 조성물 | |
| JP2003212750A (ja) | ゲル組成物および乳化組成物 | |
| JP4592347B2 (ja) | 外用剤組成物 | |
| JP4001310B2 (ja) | 脂質複合体及びこれを含有する外用組成物 | |
| JPH0899853A (ja) | 皮膚用化粧品 | |
| JP5329489B2 (ja) | 外用剤組成物 | |
| EP1093800B1 (en) | Cosmetic composition | |
| JP2010006739A (ja) | 乳化化粧料 | |
| JP2002284637A (ja) | 乳化化粧料 | |
| JPS61176511A (ja) | 可溶化型の水性透明化粧料 | |
| JPS61251606A (ja) | 化粧料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2004553151 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1020057008691 Country of ref document: KR |
|
| ENP | Entry into the national phase |
Ref document number: 2006057091 Country of ref document: US Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10534986 Country of ref document: US Ref document number: 20038A33731 Country of ref document: CN |
|
| WWP | Wipo information: published in national office |
Ref document number: 1020057008691 Country of ref document: KR |
|
| 122 | Ep: pct application non-entry in european phase | ||
| WWP | Wipo information: published in national office |
Ref document number: 10534986 Country of ref document: US |